Risk-minimisation strategies for peanut allergy

Lancet

Volumn 370, Issue 9586, 2007, Pages 483-

  O'Hehir, Robyn E ^a   Douglass, Jo A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CORTICOSTEROID;

ADOLESCENT; ADULT; ANAPHYLAXIS; ASTHMA; FOOD ALLERGY; FOOD INTAKE; HUMAN; LETTER; NUT ALLERGY; PATIENT EDUCATION; PATIENT SAFETY; PEANUT; PEANUT ALLERGY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK REDUCTION; SCHOOL CHILD;

EID: 34547687580     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61228-8     Document Type: Letter

References (5)

1. Moneret-Vautrin D., Morisset M., Flabbee J., Beaudouin E., and Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 60 (2005) 443-451
2. Mullins R. Paediatric food allergy trends in a community-based specialist allergy practice 1995-2006. Med J Aust 186 (2007) 618-621
3. Macdougall C., Cant A., and Colver A. How dangerous is food allergy in childhood?. Arch Dis Child 86 (2002) 236-239
4. Sicherer, Scott H., Simons F., and Estelle R. Self-injectable epinephrine for first-aid management of anaphylaxis. Pediatrics 119 (2007) 638-646
5. de Leon M., Rolland J., and O'Hehir R. The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy. Expert Rev Mol Med 9 (2007) 1-18